Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emerald Compounding Pharmacy is a fast-growing, FDA-registered 503A compounding pharmacy based in Tampa, Florida. Founded in 2024, the company specializes in custom sterile and non-sterile medications, with a strong focus on high-demand therapies such as weight management (including GLP-1 agonists like semaglutide and tirzepatide), hormone replacement therapies, aesthetic solutions, and peptide medications. Emerald operates primarily through provider and B2B partnerships with leading telemedicine platforms, serving patients across the United States. The pharmacy is dedicated to maintaining high standards of safety, quality, and regulatory compliance, adhering strictly to USP <795> and USP <797> standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emerald Compounding Pharmacy.